RANCHO CUCAMONGA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the third quarter ended September 30, 2015. 2015.html#sthash.HQgj3EqS.dpuf
* Net revenues of $63.9 million for the third quarter
* GAAP net loss of $3.0 million, or $0.07 per diluted share for the third quarter
Help employers find you! Check out all the jobs and post your resume.
